Epidemiology and Biostatistics
AB, Biological Science, University of Chicago; ScD, Epidemiology, Harvard University School of Public Health
Professor Evans’s research focus is in chronic viral infections, especially hepatitis B virus, and associated cancers. She has conducted research in the US, China, and Senegal in the effort to identify modifiable risk factors and interventions for these conditions. She teaches courses in infectious disease epidemiology, cancer epidemiology, and epidemiologic methods.
Professor Evans earned her B.A. in Biological Sciences at the University of Chicago, and her ScD in Epidemiology at the Harvard School of Public Health. Prior to joining the Drexel School of Public Health Faculty she was an Associate Member in the Division of Population Science at Fox Chase Cancer Center. She has served as a member of the Committee on the Prevention and Control of Viral Hepatitis Infections in the United States of the Institute of Medicine of The National Academies in Washington, DC and is an adjunct faculty member at the Hepatitis B Foundation’s public health research program.
Articles co-authored by Professor Evans have appeared in BMC Public Health, International Journal of Epidemiology, Journal of Infectious Diseases, American Journal of Gastroenterology, and other publications.
- Liver cancer/hepatocellular carcinoma
- Hepatitis B
- Cohort studies
- Early detection of cancer
- Infectious diseases
- Hepatitis B virus and other chronic viral infections
- Molecular epidemiology
- Sexually transmitted diseases
- Viral epidemiology
Evans AA, Cohen C, Block TM. Epidemiology of Hepatitis B and D. In: Kaslow RA, Stanberry LA, Leduc JW, eds. Viral Infections in Humans: Epidemiology and Control 5th ed. New York: Springer. In press 2014.
Chen G, Block JM, Evans AA, Huang P, Cohen C. Gateway to Care campaign: a public health initiative to reduce the burden of hepatitis B in Haimen City, China. BMC Public Health. 2014;14:754.
Evans AA, London WT, Gish RG, Cohen C, Block TM. Chronic HBV infection outside treatment guidelines: is treatment needed? Antivir Ther. 2013;18(2):229-235.
Institute of Medicine. Hepatitis and Liver Cancer:A National Strategy for Prevention and Control of Hepatitis B and C: The National Academies Press; 2010.
Persson EC, Graubard BI, Evans AA, London WT, Weber JP, LeBlanc A, Chen G, Lin W, McGlynn KA. Dichlorodiphenyltrichloroethane and risk of hepatocellular carcinoma. International Journal of Cancer. 2012;131(9):2078-2084.
Nie H, Evans AA, London WT, Block TM, Ren XD. Quantitative dynamics of hepatitis B basal core promoter and precore mutants before and after HBeAg seroconversion. Journal of Hepatology. 2012;56(4):795-802.
Chen G, Lin W, Shen F, Iloeje UH, London WT, Evans AA. Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. American Journal of Gastroenterology. 2006;101(8):1797-1803.
Chen G, Lin W, Shen F, Iloeje UH, London WT, Evans AA. Chronic hepatitis B virus infection and mortality from non-liver causes: results from the Haimen City cohort study. International Journal of Epidemiology. 2005;34(1):132-137.